FDA Approved: POMALIDOMIDE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Teva's supplemental application for pomalidomide (ANDA 209956), yielding a generic pomalidomide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pomalidomide (Pomalidomide)

Snippet

SUPPL AP for POMALIDOMIDE (POMALIDOMIDE)